Delivery Order 75N95022D00005-75N95024F00001
Award Date 2/15/24
Potential Completion Date 2/14/25
Potential Value $598K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92126, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $518,493 delivery order contract to Polypeptide Laboratories San Diego, LLC doing business as Polypeptide Labs. The contract is for the synthesis and distribution of opioid and related peptides, with a period of performance from February 15, 2023 through February 14, 2024. The place of performance is San Diego, California. The pricing structure is cost plus fixed fee.</p>
- This is a cost-plus-fixed-fee task order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Polypeptide Laboratories San Diego, LLC, doing business as Polypeptide Labs. The contract, valued at $595,094.00, is for the synthesis and distribution of opioid and related peptides over a one-year period of performance from February 15, 2025, to February 14, 2026. This task order is part of a larger $2,781,317...
- This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency within the National Institutes of Health (NIH), to Polypeptide Laboratories San Diego, LLC, doing business as Polypeptide Labs. The $3,332,304.82 cost-plus-fixed-fee contract is for biomedical (basic) research services, including the storage and stability testing of drug substances and products. The contract has no set-aside designation and was awarded on March 1, 2002...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Peptide 2.0 Inc., doing business as Peptide 20 Inc., for custom peptide synthesis and production services. The award, which did not utilize a small business set-aside, has a potential value of $12,801.20 and a completion date of April 22, 2019. Peptide 2.0 Inc. is a minority-owned, for-profit organization that...
- This federal contract award is for the CRUDE PEPTIDE SYNTHESIS, with a potential value of $22,593.00. The contract was awarded to A & A Labs LLC, doing business as Synthetic Biomolecules, a minority-owned, self-certified small disadvantaged business, and limited liability company. The contract is a purchase order with a firm fixed price, awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases. The place of...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Peptide 2.0 Inc., doing business as Peptide 20 Inc., a minority-owned for-profit organization, to provide HIV-1 peptides. The potential value of this contract is $12,801.20 and the period of performance ends on June 11, 2018. This award was not set aside for small businesses. Peptide 2.0 Inc. specializes in custom...
- The federal contract award is for peptide synthesis services in support of the National Institutes of Health (NIH). New England Peptide LLC was awarded an indefinite delivery/indefinite quantity (IDIQ) blanket purchase agreement (BPA) call against the NIH BPA for Peptide Synthesis and Related Services. The prime contractor will provide peptide synthesis and related services to NIH on an as-needed basis from its place of performance in Bethesda, Maryland. The contract start date was February 2,...
- This federal contract award, identified as HHSN272201500430P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to the prime contractor Atlantic Peptides LLC. The contract is for the purchase of a set of 30 peptides, each at 1 milligram and 75% purity, for a fixed price of $3,900.00. The contract has a completion date of April 3, 2015 and was awarded on March 4, 2015. No set-aside designation is...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Vivitide LLC, a manufacturer of laboratory supplies and custom peptides. The $32,500 firm fixed price contract is for the provision of peptide libraries, catalog-listed as "TIER ONE FLASHPURE," to support drug discovery and development activities. This award does not utilize any set-aside designation. Vivitide...
- This is a $81,460 firm fixed price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Pepscan Presto B.V., a foreign-owned for-profit company. The contract is for the acquisition, characterization, and optimization of constrained peptides targeting glypican, in support of the NCI's Molecular Imaging Program. The work will involve creating peptide libraries,...